Kornitzer Capital Management Inc Pfizer Inc Transaction History

Kornitzer Capital Management Inc

$5.21 Billion
Q3 2024

A detailed history of Kornitzer Capital Management Inc transactions in Pfizer Inc stock. As of the latest transaction made, Kornitzer Capital Management Inc holds 1,168,315 shares of PFE stock, worth $32.1 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares

1,168,315

Previous 1,140,753 2.42%

Holding current value

$32.1 Million

Previous $31.9 Million 5.93%

% of portfolio

0.65%

Previous 0.63%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$27.7 - $31.39 $763,467 - $865,171	27,562 Added 2.42%	1,168,315 $33.8 Million
Q2 2024 Aug 02, 2024	SELL	$25.26 - $29.6 $1.31 Million - $1.54 Million	-51,962 Reduced 4.36%	1,140,753 $31.9 Million
Q1 2024 May 01, 2024	BUY	$25.89 - $29.73 $218,951 - $251,426	8,457 Added 0.71%	1,192,715 $33.1 Million
Q4 2023 Jan 31, 2024	BUY	$26.13 - $33.94 $15,338 - $19,922	587 Added 0.05%	1,184,258 $34.1 Million
Q3 2023 Oct 31, 2023	BUY	$32.09 - $37.51 $418,581 - $489,280	13,044 Added 1.11%	1,183,671 $39.3 Million
Q2 2023 Aug 01, 2023	BUY	$36.12 - $41.79 $734,897 - $850,259	20,346 Added 1.77%	1,170,627 $42.9 Million
Q1 2023 May 09, 2023	BUY	$39.39 - $51.28 $482,685 - $628,385	12,254 Added 1.08%	1,150,281 $46.9 Million
Q4 2022 Feb 02, 2023	SELL	$41.75 - $54.5 $79,533 - $103,822	-1,905 Reduced 0.17%	1,138,027 $58.3 Million
Q3 2022 Nov 03, 2022	SELL	$43.76 - $53.42 $808,816 - $987,361	-18,483 Reduced 1.6%	1,139,932 $49.9 Million
Q2 2022 Aug 03, 2022	SELL	$46.53 - $55.17 $149,826 - $177,647	-3,220 Reduced 0.28%	1,158,415 $60.7 Million
Q1 2022 Apr 27, 2022	SELL	$45.75 - $56.69 $1.77 Million - $2.19 Million	-38,648 Reduced 3.22%	1,161,635 $60.1 Million
Q4 2021 Feb 01, 2022	SELL	$41.32 - $61.25 $455,966 - $675,893	-11,035 Reduced 0.91%	1,200,283 $70.9 Million
Q3 2021 Nov 03, 2021	SELL	$39.25 - $50.42 $73,358 - $94,234	-1,869 Reduced 0.15%	1,211,318 $52.1 Million
Q2 2021 Jul 30, 2021	BUY	$35.91 - $40.68 $29,518 - $33,438	822 Added 0.07%	1,213,187 $47.5 Million
Q1 2021 Apr 30, 2021	BUY	$33.49 - $37.77 $480,380 - $541,772	14,344 Added 1.2%	1,212,365 $43.9 Million
Q4 2020 Jan 29, 2021	SELL	$33.47 - $42.56 $264,915 - $336,862	-7,915 Reduced 0.66%	1,198,021 $44.1 Million
Q3 2020 Oct 30, 2020	SELL	$31.75 - $37.25 $55,245 - $64,815	-1,740 Reduced 0.14%	1,205,936 $44.3 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $1.09 Million - $1.32 Million	36,148 Added 3.09%	1,207,676 $39.5 Million
Q1 2020 Apr 30, 2020	SELL	$27.03 - $38.62 $50,194 - $71,717	-1,857 Reduced 0.16%	1,171,528 $38.2 Million
Q4 2019 Jan 31, 2020	SELL	$32.92 - $37.36 $465,719 - $528,531	-14,147 Reduced 1.19%	1,173,385 $46 Million
Q3 2019 Nov 04, 2019	SELL	$32.49 - $42.13 $452,260 - $586,449	-13,920 Reduced 1.16%	1,187,532 $42.7 Million
Q2 2019 Jul 31, 2019	SELL	$36.98 - $41.52 $48,813 - $54,806	-1,320 Reduced 0.11%	1,201,452 $52 Million
Q1 2019 May 01, 2019	BUY	$37.5 - $41.2 $81,150 - $89,156	2,164 Added 0.18%	1,202,772 $51.1 Million
Q4 2018 Jan 31, 2019	SELL	$38.47 - $43.86 $507,188 - $578,250	-13,184 Reduced 1.09%	1,200,608 $52.4 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $247,494 - $300,195	-7,180 Reduced 0.59%	1,213,792 $53.5 Million
Q2 2018 Aug 02, 2018	SELL	$32.98 - $35.16 $24,734 - $26,369	-750 Reduced 0.06%	1,220,972 $44.3 Million
Q1 2018 Apr 30, 2018	BUY	$31.91 - $37.02 $1.05 Million - $1.22 Million	33,015 Added 2.78%	1,221,722 $43.4 Million
Q4 2017 Jan 31, 2018	SELL	$33.26 - $35.29 $225,170 - $238,913	-6,770 Reduced 0.57%	1,188,707 $43.1 Million
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $37.1 Million - $40.8 Million	1,195,477	1,195,477 $42.7 Million

Others Institutions Holding PFE

# of Institutions

3,253

Shares Held

3.72B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $154B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kornitzer Capital Management Inc , based on Form 13F filings with the SEC.

News

Stay updated on Kornitzer Capital Management Inc with notifications on news.

Account

Kornitzer Capital Management Inc Pfizer Inc Transaction History